Roche and Seaside Therapeutics Enter Alliance to Develop Pharmacological Treatments for Autism

Source: 
http://www.marketwatch.com/story/roche-seaside-to-research-autism-treatments-2012-06-19?reflink=MW_news_stmp
Date Published: 
June 19, 2012
Abstract: 

Roche and Seaside Therapeutics have entered an alliance to develop pharmacological treatments for autism spectrum disorders and Fragile X Syndrome.